Dora K, Tsukamoto H, Suga T, Tomoo K, Suzuki A, Adachi Y
Sci Rep. 2023; 13(1):22644.
PMID: 38114553
PMC: 10730626.
DOI: 10.1038/s41598-023-49781-z.
Edemann-Callesen H, Glienke M, Akinola E, Lieser M, Habelt B, Hadar R
Mol Neurobiol. 2022; 59(12):7182-7193.
PMID: 36125729
PMC: 9616742.
DOI: 10.1007/s12035-022-03029-5.
van den Bosch R, Lambregts B, Maatta J, Hofmans L, Papadopetraki D, Westbrook A
Nat Commun. 2022; 13(1):4962.
PMID: 36002446
PMC: 9402573.
DOI: 10.1038/s41467-022-32679-1.
Fang X, Davis X, Flack K, Duncan C, Li F, White M
Front Nutr. 2022; 9:940064.
PMID: 35967820
PMC: 9369668.
DOI: 10.3389/fnut.2022.940064.
Marazziti D, Avella M, Ivaldi T, Palermo S, Massa L, Della Vecchia A
Clin Neuropsychiatry. 2021; 18(3):137-169.
PMID: 34909030
PMC: 8629054.
DOI: 10.36131/cnfioritieditore20210303.
Effects of methylphenidate on reinforcement learning depend on working memory capacity.
Rostami Kandroodi M, Cook J, Swart J, Frobose M, Geurts D, Vahabie A
Psychopharmacology (Berl). 2021; 238(12):3569-3584.
PMID: 34676440
PMC: 8629893.
DOI: 10.1007/s00213-021-05974-w.
Methylphenidate modulates interactions of anxiety with cognition.
Gaillard C, Lago T, Gorka A, Balderston N, Fuchs B, Reynolds R
Transl Psychiatry. 2021; 11(1):544.
PMID: 34675189
PMC: 8531440.
DOI: 10.1038/s41398-021-01621-2.
Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine.
Cools R, Arnsten A
Neuropsychopharmacology. 2021; 47(1):309-328.
PMID: 34312496
PMC: 8617291.
DOI: 10.1038/s41386-021-01100-8.
Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial.
Press Y, Punchik B, Kagan E, Berzak A, Freud T, Dwolatzky T
Front Med (Lausanne). 2021; 8:594228.
PMID: 33634145
PMC: 7900434.
DOI: 10.3389/fmed.2021.594228.
A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.
DesRuisseaux L, Williams V, McManus A, Gupta A, Carlyle B, Azami H
Trials. 2020; 21(1):1016.
PMID: 33308285
PMC: 7729136.
DOI: 10.1186/s13063-020-04752-x.
Methylphenidate boosts choices of mental labor over leisure depending on striatal dopamine synthesis capacity.
Hofmans L, Papadopetraki D, van den Bosch R, Maatta J, Frobose M, Zandbelt B
Neuropsychopharmacology. 2020; 45(13):2170-2179.
PMID: 32919405
PMC: 7784967.
DOI: 10.1038/s41386-020-00834-1.
Catecholaminergic Modulation of Semantic Processing in Sentence Comprehension.
Tan Y, Hagoort P
Cereb Cortex. 2020; 30(12):6426-6443.
PMID: 32776103
PMC: 7609945.
DOI: 10.1093/cercor/bhaa204.
The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls.
Lochner C, Chamberlain S, Kidd M, Taljaard L, Fineberg N, Robbins T
Psychopharmacology (Berl). 2020; 237(10):3117-3123.
PMID: 32638035
PMC: 7116135.
DOI: 10.1007/s00213-020-05597-7.
Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects.
Kalinowski L, Connor C, Somanesan R, Carias E, Richer K, Smith L
Dev Psychobiol. 2019; 62(2):170-180.
PMID: 31456229
PMC: 7028498.
DOI: 10.1002/dev.21902.
A prospective cohort study of school-going children investigating reproductive and neurobehavioral health effects due to environmental pesticide exposure in the Western Cape, South Africa: study protocol.
Chetty-Mhlanga S, Basera W, Fuhrimann S, Probst-Hensch N, Delport S, Mugari M
BMC Public Health. 2018; 18(1):857.
PMID: 29996806
PMC: 6042376.
DOI: 10.1186/s12889-018-5783-0.
Social Policy and Cognitive Enhancement: Lessons from Chess.
Mihailov E, Savulescu J
Neuroethics. 2018; 11(2):115-127.
PMID: 29937945
PMC: 5978818.
DOI: 10.1007/s12152-018-9354-y.
Methylphenidate as a cognitive enhancer in healthy young people.
Batistela S, Bueno O, Vaz L, Galduroz J
Dement Neuropsychol. 2017; 10(2):134-142.
PMID: 29213444
PMC: 5642404.
DOI: 10.1590/S1980-5764-2016DN1002009.
The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective.
Garner A, Hansen A, Baxley C, Ross M
Sports Med. 2017; 48(3):507-512.
PMID: 29198023
DOI: 10.1007/s40279-017-0829-5.
Psychostimulants As Cognitive Enhancers in Adolescents: More Risk than Reward?.
Urban K, Gao W
Front Public Health. 2017; 5:260.
PMID: 29034227
PMC: 5626934.
DOI: 10.3389/fpubh.2017.00260.
Effects of dopamine D2/D3 receptor antagonism on human planning and spatial working memory.
Naef M, Muller U, Linssen A, Clark L, Robbins T, Eisenegger C
Transl Psychiatry. 2017; 7(4):e1107.
PMID: 28440817
PMC: 5416697.
DOI: 10.1038/tp.2017.56.